NCT06879847
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Hematology Department, The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Clinical trial condition
Relapsed or Refractory Acute Myeloid Leukemia
Explore clinical trials studying Relapsed or Refractory Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.
5 public trials
2 recruiting studies
Relapsed or Refractory Acute Myeloid Leukemia trial results
Recruiting
Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia
NCT05726110
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Tao Wang Taiyuan, Shanxi, China
Not Yet Recruiting
S243249 Monotherapy in Patients With Relapsed or Refractory Acute Leukemia With a KMT2A or NUP98 Translocation or Relapsed or Refractory AML With NPM1c Mutation
NCT07722312
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
- Locations
-
Not specified
NCT04666649
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States
NCT04176393
- Conditions
- Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
- Locations
-
- Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China